Accession Number:

AD1029092

Title:

Addition of Tranexamic Acid to the Tactical Combat Casualty Care Guidelines

Descriptive Note:

Technical Report

Corporate Author:

DEFENSE HEALTH BOARD FALLS CHURCH VA FALLS CHURCH United States

Personal Author(s):

Report Date:

2011-09-23

Pagination or Media Count:

12.0

Abstract:

Traumatic hemorrhage is the leading cause of preventable death on the battlefield. A comprehensive review of the literature as provided in this report found that the antifibrinolytic tranexamic acid TXA has proven to decrease all cause mortality following major trauma. In trauma patients experiencing severe hemorrhage on the battlefield, tranexamic acid has the potential to reduce both mortality and morbidity. In light of these findings, the Defense Health Board recently approved a recommendation for the addition of tranexamic acid to the Tactical Combat Casualty Care TCCC guidelines.

Descriptors:

• Traumatic shock
• Hemorrhagic shock
• Mortality rates
• WOUNDS AND INJURIES
• BLOOD TRANSFUSIONS
• COMBAT CASUALTY CARE

Subject Categories:

• Sociology and Law
• Weapons Effects (Biological)
• Medicine and Medical Research
• Sociology and Law
• Weapons Effects (Biological)
• Medicine and Medical Research
• Sociology and Law
• Weapons Effects (Biological)

Distribution Statement:

APPROVED FOR PUBLIC RELEASE